IpIBA seminar series 2022/2023“Exploiting nanobodies targeting ABCC3 for glioblastoma immunoguided applications.”

Loading Events

«All Events

  • This event has passed.

IpIBA seminar series 2022/2023“Exploiting nanobodies targeting ABCC3 for glioblastoma immunoguided applications.”

29 November, 2022 @ 9: 30 am - 10:30 am

IpIBA seminar series 2022/2023“Exploiting nanobodies targeting ABCC3 for glioblastoma immunoguided applications.”

Tuesday, November 29th 2022 From 9:30 to 10:30

Glioblastoma is the most aggressive primary brain tumor in adults. Efficiency of current diagnostic methods and therapeutic strategies of glioblastoma is narrowed by the presence of the molecular-restrictive blood-brain barrier (BBB), and the delayed translation of relevant biomarkers into clinical practice. New efforts emerge towards a personalized medicine, based on molecularly matched formulations against specific tumor biomarkers of this heterogeneous tumor. Due to their molecular features, nanobodies emerge as novel promising immunotargeted tools for glioblastoma.


Square:

CIBA, main meeting room, and online via zoom meeting

Importantly, places are limited: 100 in person and 100 online. If you participate in person, there is no need to register online.

Sign up here

Details

Date:
November 29, 2022
Time:
9: 30 am - 10: 30 am
Event Categories:
,
Event Tags:

Organiser

IIS Aragon
See the Organizer's website